This builtin is not currently supported: Animation
- Book & Article Categories
- Collections
- Custom Solutions
- Main Menu
Book & Article Categories
- Main Menu
Book & Article Categories
Rosalind Kalb
Rosalind Kalb, Ph.D. has years of professional experience in working with people living with multiple sclerosis. MS was, is, and will be her chosen career.
Articles & Books From Rosalind Kalb
Article / Updated 07-19-2022
All eight disease-modifying medications that are approved by the U.S. Food and Drug Administration (FDA) to treat MS have been shown to be effective for people who experience relapses.So, as long as you continue to have relapses, you’re still a good candidate for most, if not all, of these medications. However, the evidence is pretty strong that these medications have their greatest impact early in the disease, primarily by reducing inflammation in the central nervous system (CNS) and reducing the number and severity of relapses.
Cheat Sheet / Updated 04-13-2022
Whether you've recently been diagnosed with multiple sclerosis (MS) or you've been living with this chronic illness for years, you want to live your life as fully and comfortably as possible. The good news is that you can! The symptoms of MS are manageable with medications, and rehabilitation strategies and treatments can reduce disease activity and slow progression.
Article / Updated 07-07-2016
Depending on your multiple sclerosis (MS) symptoms, the kind of work you do, and the environment in which you work, you’re bound to run into challenges along the way. Some of these challenges may be related to your symptoms, and others may have more to do with attitudes (yours and other people’s) about your MS.
Article / Updated 03-26-2016
Avonex, Betaseron, Extavia, Rebif, and Copaxone are the five injectable medications available for the treatment of multiple sclerosis (MS). Each of them primarily targets inflammation in the central nervous system (CNS).
Avonex, Betaseron, Extavia, and Rebif — which are all interferon beta medications — are approved for any person who experiences relapses — whether he or she has relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS), or progressive-relapsing MS (PRMS).
Article / Updated 03-26-2016
A small percentage of people taking then drug Tysabri as a treatment medication for multiple sclerosis (MS) may develop progressive multifocal leukoencephalopathy – commonly referred to as PML. PML is a rare but rapidly progressive and often fatal viral infection of the brain.
PML is thought to be caused by the John Cunningham (JC) virus, which many people (a little more than half of people) are exposed to in childhood and carry in a dormant state without ever becoming ill.
Article / Updated 03-26-2016
Some — but not all — multiple sclerosis (MS) patients who take one of the interferon beta medications (Avonex, Betaseron, Extavia, or Rebif) develop a form of antibody known as a neutralizing antibody (NAb), so called because it interferes with the biological activities of the interferon. When they occur, NAbs typically develop 12 to 18 months after the start of treatment.
Article / Updated 03-26-2016
Tysabri (natalizumab) is a laboratory-produced monoclonal antibody used for treating multiple sclerosis (MS). It works by preventing potentially damaging immune cells in the bloodstream from crossing the blood-brain barrier into the brain and spinal cord. The FDA approved it in 2006 to treat relapsing forms of MS.
Article / Updated 03-26-2016
In 2009, Dr. Paolo Zamboni — a vascular surgeon in Ferrara, Italy — introduced a phenomenon called chronic cerebrospinal venous insufficiency (CCSVI) to the MS world. Following a study of 65 people with MS, Dr. Zamboni proposed that an abnormality in blood drainage from the brain and spinal cord may contribute to nervous system damage in MS.
Article / Updated 03-26-2016
A diagnosis of multiple sclerosis (MS) means developing a strong relationship with your doctors, nurses, and other healthcare professionals. They can work with you to manage your symptoms, slow the disease course, and cope with day-to-day challenges. The following are the important members of your healthcare team:
Neurologist (or in some situations it may be a nurse practitioner or physician assistant): Diagnoses and treats MS and other neurologic diseases.
Article / Updated 03-26-2016
Some days you may feel pretty lousy when you have multiple sclerosis (MS). Other days you may feel okay or just so-so. If you’re oh-so-tired of feeling way below par, not to worry. You can improve the way you feel. These helpful tips can start you on your way to feeling healthy and well in spite of MS.
Talk with your neurologist — as early in the disease process as you can — about treatment with one of the approved disease-modifying therapies to slow disease activity and progression and reduce further nerve damage as much as possible.